Recall Register

Food, drugs, devices › Accriva Diagnostics, Inc.

Device recall: VerifyNow PRUTest Platelet Reactivity Test REF 85225 UDI-DI code: 10711234150078 The VerifyNow PRUTest is a whole blood

FDA enforcement event 97863 · Class III · initiated 21 Oct 2025 · status Ongoing

DeviceVoluntary: Firm initiated1 product recordSan Diego, CA

Accriva Diagnostics, Inc. (San Diego, CA) initiated this device recall on 21 Oct 2025; FDA lists 1 product record under event 97863, classified Class III.

FDA defines Class III as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences. 2% of the 945 device enforcement events initiated in 2025 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Accriva Diagnostics, Inc. has 6 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Accriva Diagnostics, Inc., San Diego, CA.

Reason for recall

"Due to an device without a premarket clearance being incorrectly package and distributed."

Distribution

"Worldwide - U.S. Nationwide distribution in the states of AK, CA, FL, IA, IL, MD, MI, NY, SD, and TX. The countries of Hong Kong, Japan."

Product records

Recall numberProductQuantityClassStatusReport date
Z-0500-2026VerifyNow PRUTest Platelet Reactivity Test REF 85225 UDI-DI code: 10711234150078 The VerifyNow PRUTest is a whole blood test used in the laboratory or point of care setting to measure the level of platelet P2Y12 receptor blockade.125 boxes (3,125 tests)Class IIIOngoing19 Nov 2025

Context

2%of 2025 device events are Class III945 events that year
1product record in this eventfirm median: 1
6events on this register for the firm

Other enforcement events for Accriva Diagnostics, Inc.

InitiatedProduct (first record)TypeClassRecords
30 Apr 2026directCHECK ACT-LR whole blood quality control, level 2 Model/Catalog Number: DCGLR-2DeviceClass II1
5 Nov 2025Hemochron Activated Clotting Time Low-Range Test Cuvette, REF: ACT-LR, to be used with the Hemochron Signature ELITE WhoDeviceClass II1
2 Dec 2024VerifyNow P2Y12 Platelet Reactivity Test, REF: 85064DeviceClass II1
27 Sep 2024AVOXimeter 1000E, Product Number: AVOX1000E. The AVOXimeter 1000E is a battery-operated bedside whole blood oximeter.DeviceClass II1
30 Mar 2022The VerifyNow P2Y12 Test is designed to measure platelet P2Y12 receptor blockade. Substances known to specifically blockDeviceClass II1

All 6 events for Accriva Diagnostics, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Due to an device without a premarket clearance being incorrectly package and distributed."

What does Class III mean?

FDA classifies recalls by relative degree of health hazard. Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide - U.S. Nationwide distribution in the states of AK, CA, FL, IA, IL, MD, MI, NY, SD, and TX. The countries of Hong Kong, Japan."

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.